首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献，搜索用时 62 毫秒
1.
The pharmacokinetics of oxolinic acid (OA) were investigated after a single intra‐vascular injection (20 mg kg?1 fish) in sharpsnout sea bream (90 g), a promising new euryhaline species for Mediterranean fish farming. The distribution half‐life (t1/2α) and the elimination half‐life (t1/2β) of OA were calculated to be 0.4 and 10 h respectively. The apparent volume of distribution at steady‐state (Vd(ss)) and total clearance rate (CLT) of the drug were found to be 2.1 L kg and 0.2 L kg?1 h?1 respectively. The bioavailability (F%) of OA following oral administration (40 mg kg?1 fish) was estimated to be 15%. The results indicate a rapid distribution and elimination of the drug, moderate tissue penetration, but low absorption in sharpsnout sea bream. The kinetic profile of OA found in this species is comparable with that observed in another well‐known sparid, gilthead sea bream.  相似文献   

2.
Pharmacokinetics and residue elimination of marbofloxacin (MBF) were studied in crucian carp (Carassius auratus, 250±30 g) kept at two water temperatures of 15 and 25 °C. Marbofloxacin concentrations in plasma and tissues were analysed by means of high‐performance liquid chromatography using an ultraviolet detector. The limits of detection were 0.02 μg mL?1, 0.02 μg g?1, 0.025 μg g?1, 0.02 μg g?1 and 0.025 μg g?1 in plasma and muscle, skin, liver and kidney respectively. Fish were administered orally at a single dosage of 10 mg kg?1 body weight in the PK group. The data were fitted to two‐compartment open models at both temperatures. At 15 °C, the absorption half‐life () and distribution half‐life (t1/2α) of the drug were 0.36 and 4.48 h respectively. The corresponding values at 25 °C were 0.23 and 0.87 h respectively. The elimination half‐life (t1/2β) was 50.75 h at 15 °C and 25.05 h at 25 °C. The maximum MBF concentration (Cmax) differed little between 15 (6.43 μg mL?1) and 25 °C (8.36 μg mL?1). The time to peak concentration was 1.74 h at 15 °C and 0.78 h at 25 °C. The apparent volume of distribution (Vd/F) of MBF was estimated to be 1.36 and 0.87 L kg?1 at 15 and 25 °C respectively. The area under the concentration–time curve (AUC) was 301.80 μg mL?1 h at 15 °C and 182.80 μg mL?1 h at 25 °C. The total clearance of MBF was computed as 0.03 and 0.05 L h?1 kg?1 at 15 and 25 °C respectively. After repeated oral administration at a dosage of 10 mg kg?1 body weight per day for 3 days, the results showed that the elimination half‐lives () of MBF from all tissues at 15 °C were longer than that at 25 °C. Therefore, water temperature is an important factor to be considered when deciding a reasonable withdrawal time.  相似文献   

3.
Oxytetracycline (OTC) pharmacokinetic models previously used to investigate Penaeus vannamei have not addressed the specific problems related to drug distribution/disposition in particular tissues. This study aimed to provide an insight into OTC kinetics in the hepatopancreas and muscle based on a physiological model approach. Adult male P. vannamei at the C‐D0 inter‐moulting stage were randomly assigned to intra‐sinus and oral administrations. In the intra‐sinus group, shrimps were dosed via the ventral sinus at an OTC level of 10.0 μg g?1 body weight, while in the oral one, they were force fed at a dose level of 50.2 μg g?1. The medicated animals were sampled at various time intervals until 170 h after dosing. Haemolymph, muscle and hepatopancreas samples were taken and OTC levels were determined using the validated HPLC method. A model focused on the hepatopancreas and muscle was developed. Oxytetracycline pharmacokinetic profiles in particular tissues were fitted into the model with an R2 of between 0.6568 and 0.9904. Oxytetracycline muscular distributions were essentially identical for both groups and the drug did not accumulate in muscle. The distributions in the hepatopancreas for both groups were extensive, whereas that for oral administration was approximately 2.3 times greater than that for the intra‐sinus one. It was demonstrated that hepatopancreatic OTC may undergo significant first‐pass elimination with non‐linear kinetics.  相似文献   

4.
The pharmacokinetics and tissue distribution of oxolinic acid following an intravascular administration (15 mg kg?1 fish) were determined in sea bass, Dicentrarchus labrax L. (110 g), at 13 °C and 22 °C water temperature. The kinetic profile of the drug was found to be temperature dependent, with increased temperature having a greater effect on distribution after equilibrium and the elimination phase than on the distribution process. The distibution half‐life of oxolinic acid was 1.15 and 2.76 h at 22 °C and 13 °C respectively, whereas the elimination half‐life of the drug was 55 h at 22 °C and 315 h at 13 °C. The values of the apparent volume of distribution (1.44 L kg?1 at 22 °C and 3.31 L kg?1 at 13 °C) and the volume of distribution at steady state (5.2 and 14.7 L kg?1 at the high and low temperature respectively) were considerably different between the two tested temperatures. The total body clearance of the antibiotic was found to be low (1.47 L kg?1 day?1 at 22 °C and 0.80 L kg?1 day?1 at 13 °C). Lower rates of elimination were found for the liver compared with muscle, the difference increasing with increasing temperature, while elimination rates from the serum were higher than those of other tissues, especially at the high temperature.  相似文献   

5.
Experimental diets were processed at the Oceanic Institute by adding various bioactive compounds (lutein, fucoxanthin, astaxanthins (Ax), glucosamine, carotenoid mix, phytosterol mix, bromophenol (Bp) mix or their combination) to a formulated (control) diet to examine their effects on sensory composition and growth of shrimp. These diets and a commercial feed were fed to ～1.6 g shrimp (Litopenaeus vannamei) in four replicates in an indoor laboratory under flow‐through conditions for 8 weeks. Results indicated that all the supplementations of the bioactive compounds did not improve shrimp growth (0.79–0.97 g week?1) compared with that (0.94 g week?1) of the control diet (P>0.05). However, inclusion of lutein (200 mg kg?1) or carotenoid mix (827 mg kg?1) in the control diet (with supplemental Ax) resulted in much higher free Ax (48.3 or 46.5 mg kg?1) and esterified Ax (6.2 or 3.9 mg kg?1) content in shrimp tails than the control diet (28.4; 1.4 mg kg?1 respectively) (P<0.05). Inclusion of Bp (2 mg kg?1) in the control diet resulted in higher levels of Bp (160 μg kg?1) in shrimp tail muscle than the control diet (81 μg kg?1) (P<0.05). Three free amino acids, glycine, proline and alanine might be mainly responsible for the sweet taste of L. vannamei. The results suggest that the supplementation of the bioactive compounds may not affect shrimp growth performance, but some may affect the composition and taste of shrimp.  相似文献   

6.
  相似文献   

7.
The pharmacokinetic profile of the antiparasitic agent emamectin benzoate was studied in plasma after intravenous (i.v.) injection and in plasma, muscle and skin following oral (p.o.) administration to cod, Gadus morhua, held in sea water at 9 °C and weighing 100–200 g. Following i.v. injection, the plasma drug concentration‐time profile showed two distinct phases. The plasma distribution half‐life (t1/2α) was estimated as 2.5 h, the elimination half‐life (t1/2β) as 216 h, the total body clearance (ClT) as 0.0059 L kg?1 h?1 and mean residence time (MRT) as 385 h. The volume of distribution at steady state, Vd(ss), was calculated to be 1.839 L kg?1. Following p.o. administration the peak plasma concentration (Cmax) was 15 ng mL?1, the time to peak plasma concentration (Tmax) was 89 h and t1/2β was 180 h. The highest concentration in muscle (21 ng g?1) was measured after 7 days and t1/2β was calculated to be 247 h. For skin, a peak concentration of 28 ng g?1 at 3 days was observed and a t1/2β of 235 h was determined. The bioavailability following p.o. administration was calculated to be 38%.  相似文献   

8.
In this study, we replaced fish meal with peanut meal (PM) in isonitrogenous and isolipidic diets for Pacific white shrimp at inclusion levels of 0, 70, 140, 210, 280 and 350 g kg?1. The diets were hand‐fed to three independent groups of shrimp three times a day over a 6‐week period. Shrimp fed PM diets at a level of 280 g kg?1 or higher had lower per cent weight gain compared with those fed the basal diet, whereas shrimp fed PM diets at 140 g kg?1 or higher had a lower feed utilization and protein efficiency ratio compared with shrimp fed the basal diet. The feeding rate in shrimp fed PM diets at 350 g kg?1 and the survival and protease activity in shrimp fed PM diets at 210 g kg?1 or higher were lower than that in shrimp fed the basal diet. Diets containing 280 g kg?1 or higher of PM caused an increase in the whole‐body moisture content of the shrimp, but decreased whole‐body protein and ash contents compared with the basal diet. Nutrient digestibility was lower or tended to be lower in shrimp fed a PM diet compared with those fed the basal diet. The activities of peroxidase and acid and alkaline phosphatases in plasma decreased with increasing levels of PM inclusion up to 210 g kg?1. Superoxide dismutase activity decreased at dietary PM levels of 280 g kg?1 or higher. Aflatoxin B1 residue in the muscle was not affected by any of the treatments and remained low. The data suggest that up to 140 g kg?1 of PM could be included in practical diets for Pacific white shrimp.  相似文献   

9.
The pharmacokinetic properties of the antibacterial agent oxolinic acid were studied after intravenous, intraperitoneal and oral administration to 1.5–3.0 kg Atlantic halibut, Hippoglossus hippoglossus L., held in sea water at 9 °C. Following intravenous injection, the plasma drug concentration-time profile showed two distinct phases. The terminal elimination half-life was estimated to be 52 h, whereas total body clearance (ClT) was determined to be 0.044 L kg–1 h–1. The volume of distribution at steady state, Vd(ss), was calculated to be 3.0 L kg–1, indicating good tissue penetration of oxolinic acid in Atlantic halibut. The peak plasma concentration (Cmax) and the time to peak plasma concentration (Tmax) were estimated to be 1.2 and 2.7 μg mL–1, and 21.5 and 80 h, respectively, following oral administration of medicated feed or intraperitoneal injection. The corresponding bioavailabilities were calculated to be 15% and 92%, respectively. Oral administration of vetoquinol, the carbitol ester of oxolinic acid, increased the bioavailability of oxolinic acid to 64% and the total bioavailability (oxolinic acid + vetoquinol) to 82%, whereas Cmax and Tmax values of 6.7 μg mL–1 and 14.5 h, respectively, for oxolinic acid, and 1.0 μg mL–1 and 6.3 h, respectively, for vetoquinol were obtained. Based on a minimum inhibitory concentration (MIC) of 0.0625 μg mL–1 for susceptible strains, a single intraperitoneal injection of 25 mg kg–1 of oxolinic acid maintains plasma levels in excess of 0.25 μg mL–1, corresponding to four times the MIC value, for ≈12 days. The corresponding values for a single oral dose of 25 mg kg–1 of oxolinic acid and vetoquinol were 5 and 10 days, respectively. For resistant strains with a MIC of 1 μg mL–1, a single oral dose of vetoquinol (25 mg kg–1) maintained plasma levels in excess of 4 μg mL–1 for 34 h.  相似文献   

10.
A 6‐week feeding trial was carried out in glass tanks to determine the effects of partial replacement of fish meal (FM) with a combination of meat and bone meal (MBM), poultry by‐product meal (PBM), blood meal (BM) and corn gluten meal (CGM) in practical diets on the growth, nutrient digestibility and body composition of Pacific white shrimp. Six practical diets were formulated, containing two levels of crude protein (CP) (330 and 380 g kg?1) and similar crude lipid (CL) levels. For the 330 g kg?1 dietary protein level, 0, 357 and 714 g kg?1 FM were replaced by the mixture in Diets 1–3, respectively; while 0, 514 and 784 g kg?1 FM were replaced in Diets 4–6, respectively, for 380 g kg?1 dietary protein level. White shrimp‐fed diets containing 330 g kg?1 CP had significantly lower weight gain compared with white shrimp fed diets containing 380 g kg?1 CP. Increasing the mixture and dietary protein level significantly raised the body ash content of white shrimp. White shrimp fed a low‐protein diet obtained better nutrient digestibility compared with those fed a high‐protein diet.  相似文献   

11.
A 8‐week feeding experiment was conducted to evaluate the effect of different dietary protein and lipid levels on growth and energy productive value of juvenile Litopenaeus vannamei, at 30 and 2 ppt, respectively. Nine practical diets were formulated to contain three protein levels (380, 410 and 440 g kg?1) and three lipid levels (60, 80 and 100 g kg?1). Each diet was randomly fed to triplicate groups of 30 shrimps per tank (260 L). The effects of salinity and an interaction between dietary protein level and lipid level on growth and energy productive value of shrimp were observed under the experimental conditions of this study. At 30 ppt seawater, shrimp fed with 440 g kg?1protein diets had significantly higher weight gain (WG) than those fed with 380 g kg?1 protein diets at the same dietary lipid level, and the 60 g kg?1 lipid group showed higher growth than 80 g kg?1and 100 g kg?1 lipid groups at the same dietary protein level. At 2 ppt seawater, the growth of shrimp was little affected by dietary protein treatments when shrimp fed the 80 and 100 g kg?1 lipid, shrimp fed the 80 g kg?1 lipid diets had only slightly higher growth than that fed 60and 100 g kg?1 lipid diets when fed 380 and 410 g kg?1 dietary protein diets. A significant effect of salinity on growth of shrimp was detected with the growth responses at 30 ppt > 2ppt (P < 0.05). Final body lipid content, body protein content and energy productive value of shrimp was significantly higher in animals exposed to 30 ppt than in shrimp held at 2 ppt.  相似文献   

12.
Six diets were formulated with vitamin B6 levels (2.6, 32.7, 54.8, 90.7, 119.6 and 247.4 mg kg−1, dry diet) to determine the requirement for juvenile Pacific white shrimp, Litopenaeus vannamei. Triplicate groups of 40 juvenile shrimp (approximately 1.0 g) were provided four times each day to apparent satiation (8 weeks). Weight gain (WG), specific growth rate, feeding efficiency, protein efficiency ratio (PER) and protein productive value of the shrimp were significantly influenced by the vitamin B6 levels. No significant differences in whole‐body and muscle composition, except for dry matter and protein contents in whole body. Vitamin B6 concentration in the hepatopancreas significantly increased with the dietary vitamin B6 level increasing from 2.6 to 32.7 mg kg−1. High‐density lipoprotein cholesterol in the haemolymph improved with the dietary vitamin B6 levels increasing from 2.6 to 90.7 mg kg−1 diet and no significant differences in low‐density lipoprotein cholesterol, cholesterol, glucose and total protein concentrations. Aspartate aminotransferase, alanine aminotransferase, superoxide dismutase, catalase and lysozyme in the haemolymph were significantly influenced by dietary vitamin B6 levels. The optimal dietary vitamin B6 requirements estimated using a two‐slope broken‐line model based on WG and SGR and an exponential model based on the vitamin B6 concentration in the hepatopancreas were 110.39, 110.08 and 167.5 mg kg−1, respectively.  相似文献   

13.
The experiments explored the pharmacokinetics (PK) properties of oxolinic acid (OXA) after oral administration at three dosages (10, 30 and 80 mg/kg) via medicated feed in the shrimp. The results showed that the Cmax values of 4.31, 14.93 and 16.62 mg/L and AUC0–∞ values of 92.61, 252.30 and 364.27 mg hr?1 L?1 were observed at three OXA dosage groups in the haemolymph respectively. In the hepatopancreas, Cmax values of 7.90, 27.23 and 60.51 mg/kg and AUC0–∞ values of 42.01, 133.06 and 219.06 mg hr?1 L?1 were observed at 0.5 hr post administration respectively. In the muscle, Cmax values of 1.62, 5.80 and 7.36 mg/kg and the AUC0–∞ values of 25.64, 98.10 and 134.24 mg hr?1 L?1 were observed at 2 hr post administration respectively. In the gills, Cmax values of 2.87, 8.08 and 12.12 mg/kg and the AUC0–∞ values of 51.38, 118.65 and 206.48 mg hr?1 L?1 were observed at 4 hr post administration respectively. In addition, the in vitro MIC values of OXA at three dosages against 132 strains of Vibrio were examined and showed that the minimum inhibitory concentration (MIC) values for OXA primarily ranged from 0.15–1.25 µg/ml, including eight strains of Vibrio showing MIC values ≥5 µg/ml. The MIC50 and MIC90 values of 132 strains were 0.62 and 1.25 μg/ml respectively. The AUC0–24/MIC90 ratios of Vibrio were 140.4 in 30 mg/kg group. Furthermore, the P‐glycoprotein (P‐gp) expression was determined in shrimp tissues after administration to three dosage groups (10, 30 and 80 mg/kg). The results showed that P‐gp expression was up‐regulated in the hepatopancreas (5.36‐, 13.68‐ and 31.06‐fold respectively) compared with the control group.  相似文献   

14.
This study was designed to evaluate the efficacy of eight sources (designated A–H) of soybean meal (SBM) which included six new non‐genetically modified soya varieties in practical feed formulation for Pacific white shrimp, Litopenaeus vannamei, using both growth and digestibility trials. A soybean meal‐based reference diet was formulated using conventional soybean meal (527 g kg?1 diet), which was then replaced on an isonitrogenous basis with various other experimental soybean meals. In a 6‐week growth trial, shrimp in four replicate tanks per dietary treatment (10 shrimp per tank, initial weight 0.52 ± 0.04 g) were cultured in a recirculating system. There were no significant differences with respects to per cent weight gain and survival across all dietary treatments; however, final weights and feed conversion ratio (FCR) were lower in shrimp offered diet 3. Apparent digestibility coefficients for the eight (A–H) different soybean meals were determined in L. vannamei for dry matter (ADMD), gross energy (ADE) and crude protein (ADP) using 10 g kg?1 chromic oxide as inert marker with 70 : 30 replacement techniques. Coefficients ranged from 71.3% to 88.3%, from 76.6% to 91.3% and from 93.6% to 99.8%, for ADMD, ADE and ADP, respectively. Improved digestibility values were observed in soybean C which was characterized by crude protein (471 g kg?1), crude fat (97 g kg?1), low cooking temperature (180 °C), higher nitrogen solubility index (689 g kg?1) and protein dispersibility index (619 g kg?1). This indicates that new lines of soybean meal can be used to improve digestibility coefficients in shrimp feeds.  相似文献   

15.
The experiment was conducted to determine the leucine requirement of juvenile Pacific white shrimp Litopenaeus vannamei (Boone) in low‐salinity water (0.50–1.20 g L?1). Six diets were formulated to contain 410 g kg?1 crude protein with fish meal, peanut meal and precoated crystalline amino acids with different concentration of l ‐leucine (16.72, 19.60, 22.06, 24.79, 27.28 and 30.16 g kg?1 dry diet). Each diet was randomly assigned to triplicate groups of 30 shrimps (0.38 ± 0.002 g), and the feed trial lasted for 8 weeks. The results indicated that the maximum weight gain was observed at 24.95 g kg?1 dietary leucine group, whereas the diets containing higher leucine concentration conversely reduced the growth performance (P < 0.05). Moreover, the highest body protein content and body protein deposition and the lowest haemolymph AST and ALT activities were also found at 24.95 g kg?1 dietary leucine group. With the increase in leucine in diets, a dose‐dependent increase was found in body lipid content and haemolymph urea concentration. The polynomial regression calculated using weight gain, feed efficiency and body protein deposition indicated that the optimal dietary leucine requirement for L. vannamei reared in low‐salinity water was 23.73 g kg?1 leucine of dry diet, correspondingly 57.88 g kg?1 of dietary protein.  相似文献   

16.
A modified diet was formulated for Arizona inland shrimp farming and tested as a method for reducing moult‐associated mortalities presumed due to trace mineral deficiencies. The experimental diet was supplemented with additional dietary magnesium, potassium, phospholipids and cholesterol to a commercial shrimp feed (Rangen 45/10, which was also used as the control diet). The modified diet was tested at Arizona Mariculture Associates (AMA), while the control diet was used at a nearby inland shrimp farm, Desert Sweet Shrimp Farm (DSSF). Both feeds were used throughout the culture season of 2001. Earthen pond‐reared Litopenaeus vannamei at intermoult stages (C‐D0) and ranging from 7 to 30 g were sampled at intervals for determination of haemolymph osmolality (HO). Results showed that the modified diet had not only resulted in larger size shrimp at harvest, but also improved osmoregulatory capacity (OC). HO of DSSF shrimp decreased as shrimp grew bigger, whereas HO of AMA shrimp was maintained at a stable level, or showed a slightly positive linear relationship with weight. The hyper‐OC of shrimp from AMA (462 mOsm kg?1) was greater than that from DSSF (398 mOsm kg?1). Shrimp at AMA fed the experimental diet presented no mass moult‐associated mortalities. To further investigate the iso‐osmotic point of shrimp reared in AMA, a group of six salinity gradients were designed by mixing oceanic salts into the well water to form 5, 8.5, 11.4, 14.4, 17.8, 20.7 p.p.t. medium. HO of subadult shrimp (25 g in average) were then evaluated 48 h after they had been transferred from 5 p.p.t. pond water to the medium. Shrimp HO increased with external salinity, and a plateau formed as salinity reached at 11.4 p.p.t. and higher. The iso‐osmotic point of shrimp was estimated to be 695.5 mOsm kg?1, equivalent to 26.1 p.p.t. in AMA well water.  相似文献   

17.
Postlarvae of tiger shrimp, Penaeus monodon (Fabricius), were fed semipurified diets supplemented with various levels of astaxanthin (AX) and ascorbic acid-polyphosphate (ApP): three groups were fed 230 mg AX kg?1 diet combined with 100, 1700 and 3400 mg ascorbic acid (AA) kg?1 diet, respectively; two diets contained 810 mg AX kg?1 mixed with 200 and 1700 mg AA kg?1, respectively. Each treatment was run in four replicates. Incorporated levels of AA and AX, production output, and physiological condition were recorded after 4 weeks of feeding. Whole-body AA (21-47 μg g?1) and AX, concentrations (19-35 μgg?1) were linked to dietary ApP and AX supply, respectively, although not significantly for the latter. The biomass of the group receiving the lower dietary ApP-AX combination was significantly lower than for all other treatments, i.e. 3.1 versus 3.9 g, respectively. In the groups fed 230 mg AX kg?1 diet, significant differences in stress resistance were observed according to the dietary ApP level, i.e. raising the vitamin C content in the feed from 100 to 3400 mg AA kg?1 resulted in a concomitant drop in mortality after an osmotic shock. For the treatments receiving 810 mg AX kg?1 diet, the beneficial effect of extra dietary vitamin C was not significant. An increase in the dietary AX for shrimp fed comparable ApP levels resulted in a significant drop of the stress index from 56 to 33 (cumulative mortality index). An increased resistance to salinity shock was demonstrated in association with supplementation of high dietary AA or AX levels. No conclusive results regarding possible improved disease resistance could be made since no mortality was observed after a disease challenge with Vibrio harveyi.  相似文献   

18.
The pharmacokinetics and bioavailabilities of 14C‐astaxanthin and 14C‐canthaxanthin were studied in the blood of rainbow trout following intra‐arterial (i.a.) and oral (p.o.) administration. Sixteen months old 1 kg trout were cannulated in the dorsal aorta. [6,7,6′,7′‐14C]‐keto‐carotenoids were administered i.a. and p.o. at a dose of 573.5 kBq kg?1 fish body weight for astaxanthin and 836.2 kBq kg?1 fish body weight for canthaxanthin. After i.a. distribution, total body clearance (Cltot) was 17.30±20.29 mL kg?1 of fish h?1 for 14C‐canthaxanthin and 3.30±1.50 mL kg?1 of fish h?1 for 14C‐astaxanthin. The volume of distribution at steady‐state (Vss) was 208.32±124.79 mL kg?1 of fish and 71.84±64.15 mL kg?1 of fish for 14C‐canthaxanthin and 14C‐astaxanthin respectively. Less than 0.4% of the administered radioactivity was recovered in urine. Radioactivity (expressed as percent of the dose) excreted in the bile of fish that received 14C‐canthaxanthin by i.a. route was 20‐fold higher than that observed for fish treated p.o. This ratio was lower for 14C‐astaxanthin (7.6‐fold). The mean keto‐carotenoid bioavailabilities calculated were 10–15% for both compounds. Findings suggest one daily astaxanthin application is preferable, while 12‐h time intervals between applications are preferable for canthaxanthin.  相似文献   

19.
This study investigated the effects of dietary niacin on growth performance, feed utilization and non‐specific immune response in juvenile Pacific white shrimp. Six isonitrogenous and isolipidic practical diets were formulated with graded niacin levels of 10.9, 65.8, 121.2, 203.4, 387.5 and 769.3 mg kg?1 of dry diet, respectively. Results indicated that per cent weight gain (WG), specific growth rate (SGR), feed efficiency (FE), protein efficiency ratio (PER) and protein productive value (PPV) were significantly influenced by the dietary niacin levels. The maximum WG and SGR occurred at 121.2 mg kg?1 niacin diet. However, survival and proximate composition of whole body were not significantly affected by the dietary niacin levels. Dietary niacin levels had no significant effects on the total protein, glucose, triacylglycerol and cholesterol contents in the haemolymph. The activity of catalase and lysozyme in the haemolymph was significantly affected by dietary niacin levels. Based on a two‐slope regression analysis of SGR against dietary niacin level, the dietary niacin requirement of juvenile Pacific white shrimp was 109.6 mg kg?1.  相似文献   

20.
A 35‐day feeding trial was conducted to evaluate growth, bacterial populations of the gastrointestinal tract (GIT) and immune responses of Litopenaeus vannamei fed diets containing the commercial prebiotic Previda®. Diets were formulated to contain Previda® at 0, 0.2, 0.5, 1.0 or 1.6 g kg?1 by weight. At the end of the study, differences in weight gain and survival among treatments were not significant (P > 0.05), but denaturing gradient gel electrophoresis analysis revealed that the microbial communities in the GIT changed significantly with the inclusion of dietary Previda® at different levels. Previda® was therefore able to selectively modify the microbial communities in the shrimp's GIT. Although individual bacterial species were not identified, enteric populations in shrimp fed the prebiotic at similar levels of inclusion were genetically similar. In addition, shrimp fed Previda® at 1.6 g kg?1 responded significantly (P < 0.05) better immunologically with respect to hemocyte phagocytic capacity, haemolymph protein, hyaline cell counts and haemolymph glucose compared with shrimp fed the basal diet. Although shrimp were not exposed to virulent pathogens in this study, the observed upregulation of some of imm‐une responses upon prebiotic supplementation indicates that an improved outcome of such challenges may be anticipated in Previda®‐fed shrimp under commercial conditions.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号